Zobrazeno 1 - 1
of 1
pro vyhledávání: '"M. D. Rivas Rodríguez"'
Autor:
D Gonzalez Vaquero, C Redondo Galán, M Ferris Villanueva, M. D. Rivas Rodríguez, JF Rangel Mayoral
Publikováno v:
Section 5: Patient safety and quality assurance.
Background and importance Tocilizumab is an immunosuppressive agent which has demonstrated high efficacy in clinical trials for the treatment of coronavirus because its mechanism of action seems to inhibit the inflammatory cascade Aim and objectives